GTCR Makes Strategic $200 Million Minority Investment in Dental Solutions Provider Solmetex

"Simpson Thacher advised GTCR on its strategic minority investment in Solmetex, a leading dental products provider, with a potential funding of up to $200 million. This investment aims to accelerate Solmetex's growth through both organic expansion and strategic acquisitions. Solmetex serves over 85,000 dental offices in the U.S. and has diversified its offerings to include dental waterline treatment and regenerative biomaterials. GTCR focuses on transformative investments across various sectors and has invested over $30 billion in approximately 300 companies."

Simpson Thacher represented GTCR in its strategic, structured minority investment in Solmetex, a leading provider of dental products and systems. The transaction involved a simultaneous signing and closing of the investment, which has a staged structure with potential funding of up to $200 million. This investment aims to support Solmetex's expansion strategy through organic growth and strategic acquisitions, enhancing its portfolio of dental solutions. The Simpson Thacher team included the following lawyers: Katherine Krause, Elizabeth Cooper, Iliana Karaoglan, and David Krieghbaum (M&A); Sunny Cheong and Catherine Ciriello (Capital Markets); Russell Light and Shareef Salfity (Tax); Adam Moss (Credit); Gregory Grogan, Linda Barrett, Scott Schilson, and Margaret Wang (Executive Compensation and Employee Benefits); Lori Lesser, James Talbot, Amy Candido, and Tally Smitas (Intellectual Property); Vanessa Burrows and Jacob Madden (Healthcare Regulatory); and Kelly Karapetyan (Antitrust).

GTCR Makes Strategic $200 Million Minority Investment in Dental Solutions Provider Solmetex

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads